Chemical formula: C₁₁H₁₇NO₃ Molecular mass: 211.258 g/mol PubChem compound: 4086
Orciprenaline sulphate is a bronchodilating agent. The bronchospasm associated with various pulmonary diseases-chronic bronchitis, pulmonary emphysema, bronchial asthma, silicosis, tuberculosis, sarcoidosis and carcinoma of the lung, has been successfully reversed by therapy with orciprenaline sulphate.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03AB03 | Orciprenaline | R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AB Non-selective beta-adrenoreceptor agonists |
| R03CB03 | Orciprenaline | R Respiratory system → R03 Drugs for obstructive airway diseases → R03C Adrenergics for systemic use → R03CB Non-selective beta-adrenoreceptor agonists |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| ORCIPRENALINE Syrup | Health Products and Food Branch (CA) | MPI, CA: SPM |
Metaproterenol is an active ingredient of these brands:
Mexico (MX)
South Africa (ZA)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
